Riskpilot← Back to searchSign inGet full accessBUDOLFI HØREKLINIK ApS
APSActiveCVR 32157092Budolfi Plads 1Retail sale of medical and orthopaedic goods · NACE 4774Est. 20093 employeeswww.lydtillivet.dk
Revenue 2024
DKK 3,1M
+22% vs 2023
EBITDA margin
50.2%
+148% vs 2023
Equity ratio
50.8%
Financial strength
Net profit 2024
DKK 1,1M
+156% vs 2023
| Revenue | DKK 3,1M | +22% |
| EBITDA | DKK 1,6M | +148% |
| Net profit | DKK 1,1M | +156% |
| Total assets | DKK 3,2M | +82% |
| Equity | DKK 1,6M | +66% |
| Employees | 3 | — |
Legal name
BUDOLFI HØREKLINIK ApS
CVR number
32157092
Legal form
Anpartsselskab
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
19. maj 2009
Share capital
DKK 125.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør i forening med et bestyrelsesmedlem.
Company purpose
Selskabets formål er at drive høreklinik med salg af høreapparater samt andre hertil beslægtede produkter.
Address
Budolfi Plads 1
Phone
+4598134089
Email
info@lydtillivet.dk
Website
www.lydtillivet.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3.542 | 2.904 | 2.816 | 2.692 | 4.885 | 5.185 | 3.159 | 2.615 | 3.488 | 3.085 | 2.759 | 2.563 | 3.135 |
| Staff expenses | -1.877 | -1.858 | -1.960 | -1.645 | -2.233 | -2.301 | -2.229 | -1.850 | -1.629 | -1.711 | -1.951 | -1.927 | -1.561 |
| EBITDA | 1.665 | 1.046 | 857 | 1.048 | 2.652 | 2.885 | 930 | 765 | 611 | 1.375 | 808 | 636 | 1.574 |
| Depreciation & amort. | -210 | -211 | -189 | -90 | -40 | -36 | -39 | -40 | -54 | -94 | -94 | -83 | -70 |
| EBIT | 1.455 | 835 | 668 | 957 | 2.612 | 2.849 | 891 | 725 | 556 | 1.281 | 714 | 553 | 1.505 |
| Net financials | -36 | -19 | -20 | -16 | -13 | -23 | 209 | -17 | -370 | 165 | -645 | 13 | -31 |
| Profit before tax | 1.419 | 816 | 648 | 941 | 2.598 | 2.826 | 1.100 | 708 | 186 | 1.446 | 69 | 566 | 1.474 |
| Tax | 360 | 212 | 169 | 228 | 578 | 630 | 197 | 158 | 391 | 281 | 156 | 120 | 331 |
| Net profit | 1.059 | 604 | 479 | 713 | 2.021 | 2.196 | 903 | 549 | -205 | 1.165 | -88 | 446 | 1.143 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 4.517 | 3.578 | 3.516 | 3.818 | 5.544 | 5.442 | 4.662 | 4.851 | 3.755 | 3.493 | 1.429 | 1.740 | 3.171 |
| Equity | 2.159 | 1.763 | 2.117 | 2.329 | 3.637 | 3.196 | 2.099 | 2.149 | 1.443 | 2.109 | 521 | 967 | 1.609 |
| Long-term debt | 1.000 | 500 | 500 | 500 | 500 | 500 | 897 | 531 | 85 | 47 | 0 | 0 | 0 |
| Short-term debt | 1.331 | 1.305 | 899 | 988 | 1.407 | 1.747 | 1.666 | 2.170 | 2.227 | 1.338 | 908 | 773 | 1.562 |
| Total debt | 2.331 | 1.805 | 1.399 | 1.488 | 1.907 | 2.247 | 2.563 | 2.701 | 2.312 | 1.384 | 908 | 773 | 1.562 |
EBITDA margin
50.2%
This company
15.8%
Market median
+218% vs market
20122024
Equity ratio
50.8%
This company
38.2%
Market median
+33% vs market
20122024
Return on equity
71.0%
This company
18.4%
Market median
+286% vs market
20122024
Net profit margin
36.4%
This company
8.1%
Market median
+349% vs market
20122024
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20122024
Debt / equity
0.97×
This company
0.62×
Market median
+56% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HT Management | Management | 2016 | — | — |
KM Founder | Founder | 2009 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2015 | — | — | |
| Board of Directors | 2026 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Heidi Kock Holding ApS | Company | 25.0% | 25.0% | 2026 |
Speciallægeselskabet Pascal Bonvin ApS | Company | 15.0% | 15.0% | 2026 |
SPECIALLÆGESELSKABET MIKKEL ATTERMANN BRUHN ApS | Company | 15.0% | 15.0% | 2026 |
SPECIALLÆGESELSKABET JANUS BO BECHMANN JESPERSEN ApS | Company | 15.0% | 15.0% | 2026 |
GRAVES ApS | Company | 15.0% | 15.0% | 2026 |
| Individual | 20.0% | 20.0% | 2009 | |
Speciallæge Peder Chr. Frandsen ApS | Company | 20.0% | 25.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPECIALLÆGESELSKABET MIKKEL ATTERMANN BRUHN ApS
BUDOLFI HØREKLINIK ApS Board members of BUDOLFI HØREKLINIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Heidi Thestrup Kock | Management | 0 companies |
| Kirsten Møller Sander | Founder | 0 companies |
| Pascal Antoine Bonvin | Board of Directors | 0 companies |
| Peder Christian Frandsen | Board of Directors | 0 companies |
| Mikkel Attermann Bruhn | Board of Directors | 0 companies |
| Janus Bo Bechmann Jespersen | Board of Directors | 0 companies |